Circulating cell-derived microparticles in women with pregnancy loss.

Jaume Alijotas-Reig, Carles Palacio-Garcia, Immaculada Farran-Codina, Cristina Zarzoso, Luis Cabero-Roura, Miquel Vilardell-Tarres

Research output: Contribution to journalArticleResearchpeer-review

30 Citations (Scopus)


To analyze cell-derived microparticles (cMP) in pregnancy loss (PL), both recurrent miscarriages (RM) and unexplained fetal loss (UFL). Non-matched case-control study was performed at Vall d'Hebron Hospital. Cell-derived microparticles of 53 PL cases, 30 with RM, 16 with UFL, and 7 (RM + UFL), were compared to 38 healthy pregnant women. Twenty healthy non-pregnant women act as controls. Cell-derived microparticles were analyzed through flow cytometry. Results are given as total annexin (A5+), endothelial-(CD144+/CD31+ CD41-), platelet-(CD41+), leukocyte-(CD45+) and CD41- c-MP/μL of plasma. Antiphospholipid antibodies (aPLA) were analyzed according to established methods. Comparing PL versus healthy pregnant, we observed a significant endothelial cMP decrease in PL. When comparing RM subgroup with controls, we observed significant decreases in endothelial cMP. When comparing the PL positive for aPLA versus PL-aPLA-negative, no cMP numbering differences were seen. Pregnancy loss seems to be related to endothelial cell activation and/or consumption. A relationship between aPLA and cMP could not be demonstrated. © 2011 John Wiley & Sons A/S.
Original languageEnglish
Pages (from-to)199-208
JournalAmerican journal of reproductive immunology (New York, N.Y. : 1989)
Issue number3
Publication statusPublished - 1 Jan 2011


Dive into the research topics of 'Circulating cell-derived microparticles in women with pregnancy loss.'. Together they form a unique fingerprint.

Cite this